How does HUAK's PE Ratio compare to its peers?

HUAK is good value based on its Price-To-Earnings Ratio (10.8x) compared to the peer average (14.5x).

How does HUAK's PE Ratio compare vs other companies in the US Food Industry?

HUAK is good value based on its Price-To-Earnings Ratio (10.8x) compared to the US Food industry average (16.7x).

What is HUAK's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate HUAK's Price-To-Earnings Fair Ratio for valuation analysis.

What is the Fair Price of HUAK when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate HUAK's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

HUAK Stock Overview

Huake Holding Biology Co., Ltd. produces and sells camellia seed oil products. More details

HUAK fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	5/6
Financial Health	6/6
Dividends	0/6

Rewards

Price-To-Earnings ratio (10.8x) is below the US market (16.4x)

Earnings grew by 80.6% over the past year

Risk Analysis

Shares are highly illiquid

Does not have a meaningful market cap ($31M)

My Notes

Capture your thoughts, links and company narrative

Huake Holding Biology Co., LTD. Competitors

Oriental Rise Holdings

NasdaqCM:ORIS

US$30.2m

Coffee Holding

NasdaqCM:JVA

US$21.2m

Industrias Bachoco. de

OTCPK:IDBH.F

US$9.7m

Top Wealth Group Holding

NasdaqCM:TWG

US$5.6m

Price History & Performance

Summary of share price highs, lows and changes for Huake Holding Biology
Historical stock prices
Current Share Price	US$5.00
52 Week High	US$0
52 Week Low	US$0
Beta	0
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	0%

Recent updates

Shareholder Returns

	HUAK	US Food	US Market
7D	n/a	-5.0%	-3.5%
1Y	n/a	-5.2%	22.1%

Return vs Industry: Insufficient data to determine how HUAK performed against the US Food industry.

Return vs Market: Insufficient data to determine how HUAK performed against the US Market.

Price Volatility

Is HUAK's price volatile compared to industry and market?
HUAK volatility
HUAK Average Weekly Movement	n/a
Food Industry Average Movement	4.8%
Market Average Movement	6.3%
10% most volatile stocks in US Market	17.0%
10% least volatile stocks in US Market	3.1%

Stable Share Price: HUAK has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine HUAK's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2019	27	Pingting Wang	www.aokaifa.ns2.mfdns.com

Huake Holding Biology Co., Ltd. produces and sells camellia seed oil products. It sells its products through direct sales, sales exhibitions, franchising, and online distribution channels. The company also exports its products to Taiwan, Hong Kong, and Southeast Asia.

Huake Holding Biology Co., LTD. Fundamentals Summary

How do Huake Holding Biology's earnings and revenue compare to its market cap?
HUAK fundamental statistics
Market cap	US$31.25m
Earnings (TTM)	US$2.90m
Revenue (TTM)	US$21.11m

10.8x

P/E Ratio

1.5x

P/S Ratio

Is HUAK overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
HUAK income statement (TTM)
Revenue	US$21.11m
Cost of Revenue	US$17.03m
Gross Profit	US$4.08m
Other Expenses	US$1.18m
Earnings	US$2.90m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)	0.46
Gross Margin	19.35%
Net Profit Margin	13.74%
Debt/Equity Ratio	0%

How did HUAK perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2022/12/22 09:20
End of Day Share Price	2022/12/21 00:00
Earnings	2022/03/31
Annual Earnings	2021/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Huake Holding Biology Co., LTD. is covered by 0 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution

Huake Holding Biology NasdaqCM:HUAK Stock Report